U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C21H26N2O2
Molecular Weight 338.4433
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EPICAINIDE

SMILES

CCN1CCCC1CNC(=O)C(O)(C2=CC=CC=C2)C3=CC=CC=C3

InChI

InChIKey=LMXFPUVUUSHCMM-UHFFFAOYSA-N
InChI=1S/C21H26N2O2/c1-2-23-15-9-14-19(23)16-22-20(24)21(25,17-10-5-3-6-11-17)18-12-7-4-8-13-18/h3-8,10-13,19,25H,2,9,14-16H2,1H3,(H,22,24)

HIDE SMILES / InChI
Molecular Formula C21H26N2O2
Molecular Weight 338.4433
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

There is no information about pharmacological and biological properties of epicainide. It is known, that drug was a potent antiarrhythmic agent.

Approval Year

Unknown
139594
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Differences in the metabolism of epicainide in rats and man.
1989 Jan
Patents

Patents

20050002865
228
6331289
128
8158152
108
9016221
110
WO2006014484A2
134

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:11:25 GMT 2023
Edited
by admin
on Sat Dec 16 17:11:25 GMT 2023
Record UNII
DZY7AR1B0U
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EPICAINIDE
INN  
INN  
Official Name English
N-((1-ETHYL-2-PYRROLIDINYL)METHYL)BENZILAMIDE
Systematic Name English
epicainide [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C47793
Created by admin on Sat Dec 16 17:11:25 GMT 2023 , Edited by admin on Sat Dec 16 17:11:25 GMT 2023
Code System Code Type Description
MESH
C060578
Created by admin on Sat Dec 16 17:11:25 GMT 2023 , Edited by admin on Sat Dec 16 17:11:25 GMT 2023
PRIMARY
PUBCHEM
68862
Created by admin on Sat Dec 16 17:11:25 GMT 2023 , Edited by admin on Sat Dec 16 17:11:25 GMT 2023
PRIMARY
INN
4531
Created by admin on Sat Dec 16 17:11:25 GMT 2023 , Edited by admin on Sat Dec 16 17:11:25 GMT 2023
PRIMARY
ChEMBL
CHEMBL2107538
Created by admin on Sat Dec 16 17:11:25 GMT 2023 , Edited by admin on Sat Dec 16 17:11:25 GMT 2023
PRIMARY
EVMPD
SUB06562MIG
Created by admin on Sat Dec 16 17:11:25 GMT 2023 , Edited by admin on Sat Dec 16 17:11:25 GMT 2023
PRIMARY
FDA UNII
DZY7AR1B0U
Created by admin on Sat Dec 16 17:11:25 GMT 2023 , Edited by admin on Sat Dec 16 17:11:25 GMT 2023
PRIMARY
EPA CompTox
DTXSID1057799
Created by admin on Sat Dec 16 17:11:25 GMT 2023 , Edited by admin on Sat Dec 16 17:11:25 GMT 2023
PRIMARY
SMS_ID
100000080450
Created by admin on Sat Dec 16 17:11:25 GMT 2023 , Edited by admin on Sat Dec 16 17:11:25 GMT 2023
PRIMARY
NCI_THESAURUS
C72580
Created by admin on Sat Dec 16 17:11:25 GMT 2023 , Edited by admin on Sat Dec 16 17:11:25 GMT 2023
PRIMARY
CAS
66304-03-8
Created by admin on Sat Dec 16 17:11:25 GMT 2023 , Edited by admin on Sat Dec 16 17:11:25 GMT 2023
PRIMARY
Related Record Type Details
Structure of EPICAINIDE, (S)-
ENANTIOMER -> RACEMATE
Structure of EPICAINIDE, (R)-
ENANTIOMER -> RACEMATE
Related Record Type Details
Structure of EPICAINIDE
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966